Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.
Centre of Membrane Proteins and Receptors, University of Birmingham and University of Nottingham, Midlands, UK.
FASEB J. 2022 Apr;36(4):e22214. doi: 10.1096/fj.202101945R.
Adenosine is a local mediator that regulates changes in the cardiovascular system via activation of four G protein-coupled receptors (A , A , A , A ). Here, we have investigated the effect of A and A -selective agonists on vasodilatation in three distinct vascular beds of the rat cardiovascular system. NanoBRET ligand binding studies were used to confirm receptor selectivity. The regional hemodynamic effects of adenosine A and A selective agonists were investigated in conscious rats. Male Sprague-Dawley rats (350-450 g) were chronically implanted with pulsed Doppler flow probes on the renal artery, mesenteric artery, and the descending abdominal aorta. Cardiovascular responses were measured following intravenous infusion (3 min for each dose) of the A -selective agonist CGS 21680 (0.1, 0.3, 1 µg kg min ) or the A -selective agonist BAY 60-6583 (4,13.3, 40 µg kg min ) following predosing with the A -selective antagonist SCH 58261 (0.1 or 1 mg kg min ), the A /A antagonist PSB 1115 (10 mg kg min ) or vehicle. The A -selective agonist CGS 21680 produced a striking increase in heart rate (HR) and hindquarters vascular conductance (VC) that was accompanied by a significant decrease in mean arterial pressure (MAP) in conscious rats. In marked contrast, the A -selective agonist BAY 60-6583 significantly increased HR and VC in the renal and mesenteric vascular beds, but not in the hindquarters. Taken together, these data indicate that A and A receptors are regionally selective in their regulation of vascular tone. These results suggest that the development of A receptor agonists to induce vasodilatation in the kidney may provide a good therapeutic approach for the treatment of acute kidney injury.
腺苷是一种局部介质,通过激活四种 G 蛋白偶联受体(A 、A 、A 、A )来调节心血管系统的变化。在这里,我们研究了 A 和 A 选择性激动剂对大鼠心血管系统三个不同血管床血管舒张的影响。使用 NanoBRET 配体结合研究来确认受体选择性。在清醒大鼠中研究了腺苷 A 和 A 选择性激动剂的区域性血液动力学效应。雄性 Sprague-Dawley 大鼠(350-450 g)在肾动脉、肠系膜动脉和降主动脉上慢性植入脉冲多普勒流量探头。在预给予 A 选择性拮抗剂 SCH 58261(0.1 或 1 mg kg min )、A /A 拮抗剂 PSB 1115(10 mg kg min )或载体后,静脉输注(每种剂量 3 分钟)A 选择性激动剂 CGS 21680(0.1、0.3、1 µg kg min )或 A 选择性激动剂 BAY 60-6583(4、13.3、40 µg kg min ),测量心血管反应。A 选择性激动剂 CGS 21680 显著增加心率(HR)和后肢血管传导率(VC),同时清醒大鼠的平均动脉压(MAP)显著降低。相比之下,A 选择性激动剂 BAY 60-6583 显著增加了肾和肠系膜血管床的 HR 和 VC,但在后肢没有增加。综上所述,这些数据表明 A 和 A 受体在血管张力调节方面具有区域性选择性。这些结果表明,开发 A 受体激动剂诱导肾脏血管舒张可能为治疗急性肾损伤提供一种良好的治疗方法。